SNMMI and IAC Collaborate on New Radiopharmaceutical Therapy Accreditation Program

June 25, 2023

Chicago (Embargoed until 9:30 am CDT, Sunday, June 25, 2023)—The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Intersocietal Accreditation Commission (IAC) are pleased to announce an enhanced partnership that will help ensure quality care for patients receiving radiopharmaceutical therapy. The partnership will feature a new Radiopharmaceutical Therapy accreditation program that will provide facilities with a mechanism for demonstrating their commitment to quality and patient safety in radiopharmaceutical therapy.

The new Radiopharmaceutical Therapy accreditation program augments the existing IAC accreditation areas of Nuclear Cardiology, General Nuclear Medicine and Positron Emission Tomography (PET).

“Radiopharmaceutical therapy is a powerful technique for treating cancer that is now being used to great benefit in patients with prostate and other cancers. It is essential that patients receiving radiopharmaceutical therapy be confident that their providers meet high standards of training and experience. The new SNMMI-IAC Radiopharmaceutical Therapy accreditation helps assure that sites delivering radiopharmaceutical therapy are qualified and experienced, have appropriate facilities and equipment, and can offer safe and reliable radiopharmaceutical therapy,” said Richard L. Wahl, MD, SNMMI Immediate Past President and IAC Nuclear/PET Board member.

“IAC and SNMMI have worked together for many years, as SNMMI is a founding sponsoring organization of the IAC Nuclear/PET accreditation program. The creation of the new Radiopharmaceutical Therapy accreditation offering is possible through our collaboration and leverages both organizations’ strengths toward our aligned missions focused on quality and safe patient care. Through a multi-specialty approach, the SNMMI representatives along with our other sponsoring organizations, have contributed greatly to the development of standards for radiopharmaceutical therapy, ensuring that they are reflective of SNMMI guidelines and current best practices that lead to improved patient care,” said Howard Lewin, MD, FACC, FASNC, President of the IAC Nuclear/PET Board of Directors.

“SNMMI is excited about this accreditation program because it builds upon both the SNMMI Radiopharmaceutical Therapy Centers of Excellence and the IAC nuclear medicine accreditation programs,” said SNMMI President Munir Ghesani, MD, FACNM, FACR.

Facilities interested in receiving information about the new program are encouraged to visit intersocietal.org/programs/nuclear-pet to complete an interest form for the Radiopharmaceutical Therapy program.
                                                                        

###
 

About the Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit http://www.snmmi.org.

About the Intersocietal Accreditation Commission

The IAC is a nonprofit organization in operation to evaluate and accredit facilities that provide diagnostic imaging, interventional and therapeutic procedures, thus improving the quality of patient care provided in private offices, clinics and hospitals where such services are performed. The IAC provides accreditation programs for vascular testing, echocardiography, nuclear/PET/radiopharmaceutical therapy, MRI, diagnostic CT, dental CT, carotid stenting, vascular interventional, cardiac electrophysiology and cardiovascular catheterization. The IAC programs for accreditation are dedicated to ensuring quality patient care and promoting health care and all support one common mission: Improving health care through accreditation®. Committed to its mission through a rigorous peer review process, the IAC has granted accreditation to more than 14,000 sites since its inception in 1991. To learn more about IAC, visit intersocietal.org.